OCC 20.9% 66.5¢ orthocell limited

Further CelGro® nerve clinical trial data from all patients at 12 months, page-8

  1. 790 Posts.
    lightbulb Created with Sketch. 126
    Some have, but we don't have the money or backing needed to take a big enough slice. 150 people taking 1 million shares each could control this company. Unfortunately most own under 50,000.
 
watchlist Created with Sketch. Add OCC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.